Table 2 Tissue specificity of differentially expressed gene profiles

Epithelium

636

1.56

1.50E-34

4.99E-34

616

1.56

1.36E-32

4.54E-32

682

1.53

1.20E-34

3.92E-34

Liver

476

1.48

2.68E-19

1.79E-18

464

1.48

7.21E-19

4.82E-18

516

1.46

2.04E-20

1.33E-19

Brain

1443

1.17

4.35E-16

4.36E-15

1400

1.17

1.55E-14

1.55E-13

1566

1.16

5.17E-16

5.07E-15

Skin

360

1.28

6.81E-06

1.59E-04

351

1.28

8.22E-06

1.92E-04

392

1.28

2.63E-06

6.02E-05

Lymph

152

1.46

3.10E-05

8.28E-04

148

1.47

4.44E-05

0.001

157

1.38

3.98E-04

0.016

Bone marrow

160

1.41

1.76E-04

0.005

158

1.43

8.78E-05

0.003

178

1.43

1.45E-05

0.000

Muscle

170

1.34

0.001

0.049

167

1.35

9.43E-04

0.035

189

1.36

1.46E-04

0.005

Cajal-Retzius cell

53

1.75

0.001

0.056

52

1.77

0.001

0.055

56

1.69

0.002

0.079

Skeletal muscle

123

1.38

0.003

0.170

122

1.41

0.002

0.079

141

1.45

0.000

0.004

Colon

229

1.25

0.003

0.179

224

1.26

0.003

0.157

238

1.19

0.035

2.520

Fetal brain cortex

55

1.65

0.004

0.208

54

1.67

0.004

0.196

59

1.62

0.004

0.181

Heart

119

1.34

0.013

0.791

112

1.29

0.043

3.784

130

1.34

0.008

0.433

Renal cell carcinoma

21

2.17

0.017

1.111

21

2.23

0.013

0.777

21

1.99

0.042

3.417

Lung

453

1.13

0.030

2.239

447

1.15

0.013

0.811

504

1.15

0.005

0.249

Hepatoma

54

1.49

0.038

2.953

54

1.54

0.023

1.605

59

1.49

0.026

1.717

Embryonal rhabdomyosarcoma

9

3.34

0.043

3.425

9

3.43

0.036

2.866

Kidney

265

1.18

0.034

2.526

300

1.19

0.013

0.767

Fetal liver

48

1.53

0.042

3.529

Teratocarcinoma

120

1.29

0.034

2.585

Aorta

36

1.66

0.035

2.768